1Callreus T, Hoghmd P. Pharmacokinetics and anti-diuretic effect of intravenous administration of desmopressin in orally overhydrated male volunteers[J]. Pharmacol Toxicol, 1998, 83 (12) :259-262.
2Kaufmann J E, Vischer U M. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP) [J]. J Thromb Haemostasis, 2003,1(5):682-689.
3Schwartz W B, Bennett W, Curelop S, et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretie hormone[J]. J Am Soc Nephrol, 2001, 12 (6) :2860-2870.
4Huguemn R L, Sturmer E, Boissomnas R A , et al. Desmorpressin arginine vasopressin, an analogue of arginine vasopressin with anti- diuretic activity[J]. Experientia, 1961, 15 (7) :68-73.
6Adrian Schreiber, Sebastian Kubitza, Friedrich C Luft. A woman with postoperative hyponatremia related to desmopressin acetate[J]. American Journal of Kidney Diseases, 2004, 44 ( 1 ) :33-36.
8Martha B, Donoghue M, Elizabeth Latimer, et al. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis[J]. Arch Pediatr Adolesc Med, 1998, 152 (65) :290-292.
8Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders the first 20 years [J]. Blood, 1997, 90 (7) : 2515-2521.
9Miesbach W, Krekeler S, Dfick O, et al. Clinical assessment of e{ficaey andsafety of DDAVP[J]. Hamostaseologie, 2010: s172- s175.
10Bilton D,Webb AK, Foster H, et al. Life threateninghaemopty- sis in cysticfibrosis: an alternativetherapeutic approach [J]. Thorax, 1990,45 :976-978.
